1. National Cancer Institute. CAR T cells: engineering patients’ immune cells to treat their cancers. Updated March 10, 2022. Available at: https://www.cancer.gov/about-cancer/treatment/research/car-t-cells. Accessed August 24, 2022.
2. Grady D. Cell therapy shows promise for acute type of leukemia. The New York Times. March 20, 2013. Available at: https://www.nytimes.com/2013/03/21/health/altered-t-cell-therapy-shows-promise-for-acute-leukemia.html. Accessed August 24, 2022.
3. Novartis Pharmaceuticals Corporation. Kymriah (tisagenlecleucel): official patient website. 2022. Available at:https://www.us.kymriah.com/. Accessed August 24, 2022.
4. US Food and Drug Administration. Press Announcements. FDA approval brings first gene therapy to the United States. August 30, 2017. Available at:https://www.fda.gov/news-events/press-announcements/fda-approval-brings-first-gene-therapy-united-states. Accessed August 24, 2022.
5. Foundation for the Accreditation of Cellular Therapy, The Joint Accreditation Committee – ISCT and EBMT. Immune effector cell standards. First Edition, Version 1.1. Available at: https://www.factglobal.org/standards/immune-effector-standards. Accessed August 24, 2022.